Divi's Labs
-US FDA issues import alert for Visakhapatnam unit-II
Alert
-US FDA issued five observations to Divi's Vizag unit in December
-US FDA inspected Divi's Vizag unit from November 29-December 6
Unichem Labs
-US FDA inspected Goa unit from March 14-20, few observations made
-Observations made by US FDA are correctable, will file response soon
Aurobindo Pharma
-Gets USFDA nod for Guaifenesin & Dextromethorphan hydrobromide ER tablets
-Product will be launched from Q1FY18
SBI
-Board meet on March 24 to consider issue of unsecured debt up to USD 1.5 billion
-Board meet on March 24 to approve & allot shares to units
For more information Call us ✆ +91 7400-734000 or Visit Dollar Advisory
-US FDA issues import alert for Visakhapatnam unit-II
Alert
-US FDA issued five observations to Divi's Vizag unit in December
-US FDA inspected Divi's Vizag unit from November 29-December 6
Unichem Labs
-US FDA inspected Goa unit from March 14-20, few observations made
-Observations made by US FDA are correctable, will file response soon
Aurobindo Pharma
-Gets USFDA nod for Guaifenesin & Dextromethorphan hydrobromide ER tablets
-Product will be launched from Q1FY18
SBI
-Board meet on March 24 to consider issue of unsecured debt up to USD 1.5 billion
-Board meet on March 24 to approve & allot shares to units
For more information Call us ✆ +91 7400-734000 or Visit Dollar Advisory
No comments:
Post a Comment